News | January 10, 2024
Lupin Launches Bromfenac Ophthalmic Solution, 0.07% in US
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
HIFU is a state-of-the-art treatment that utilizes high-frequency sound waves to target and destroy prostate cancer cells
Medway setup a state-of-the-art Heart Institute in Chennai
The company has received five final approvals
NEIAFMR to be developed as the national hub for folk medicine
This acquisition marks Max Healthcare's entry into Lucknow
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain
Rocuronium Bromide Injection had estimated annual sales of USD 54 million in the US (IQVIA MAT August 2023).
RHTC will address a long-standing healthcare access issue for all the local population
Subscribe To Our Newsletter & Stay Updated
